LUKE EVNIN Insider Trading $MBRX METABASIS THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is Director in OSCIENT PHARMACEUTICALS CORP ($GENE) and 10% Owner in VIACELL INC ($VIAC) and in BARRIER THERAPEUTICS INC ($BTRX) and 10% Owner in BARRIER THERAPEUTICS INC ($BTRX) and 10% Owner in TERCICA INC ($TRCA) and 10% Owner in COTHERIX INC ($CTRX) and Director in METABASIS THERAPEUTICS INC ($MBRX).
LUKE EVNIN in METABASIS THERAPEUTICS INC
Trading Symbol: MBRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKE EVNIN: Director
Holdings: 4,497,978 shares
Current Value: $8,096,360
Latest Transaction: Oct 04 2005
$MBRX Market Capitalization: $18.08M
$MBRX Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LUKE EVNIN in METABASIS THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BTRX, CTRX, MBRX, GENE, TRCA, VIAC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 04 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | P | 6.74 | 244,881 | 1,650,498 | 244,881 | |
Oct 04 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Sell | P | 5.86 | 699,659 | 4,100,002 | 4,497,978 | 5.2 M to 4.5 M (-13.46 %) |
May 19 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 2.65 | 10,000 | 26,500 | 10,000 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 9.11 | 217,780 | 1,984,520 | 217,780 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 6.08 | 450,979 | 2,739,697 | 450,979 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 1.50 | 1,262,295 | 1,893,443 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 1.00 | 2,739,711 | 2,739,711 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 6,923,077 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 5,737,704 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 7,969,230 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | P | 7.00 | 357,000 | 2,499,000 | 3,798,319 | 3.4 M to 3.8 M (+10.37 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,139,599 | 0 | 3,441,319 | 2.3 M to 3.4 M (+49.51 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 989,914 | 0 | 2,301,720 | 1.3 M to 2.3 M (+75.46 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,311,806 | 0 | 1,311,806 | 0 to 1.3 M |
Page: 1